Julie Rhoades, Ph.D.
Professor, Medicine, Division of Hematology & Oncology
Director, NCI T-32 Program
The Sterling lab uses multi-disciplinary approaches including molecular biology, pre-clinical models, engineering, and imaging to investigate how the bone micro-environment regulates tumor establishment in bone and bone destruction with a specific focus on identifying new therapeutic targets.